 |
| JUly
10, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
- Arcus Biosciences: Quemliclustat Receives
Orphan Drug Designation for Pancreatic Cancer
More
- BeOne Medicines: European Commission
Approves TEVIMBRA in Combination With
Chemotherapy as a First-Line Treatment for
Nasopharyngeal Carcinoma More
- Buck Institute: Awarded DARPA Contract to
Pioneer Next-Gen AI Modeling Platform More
- Intuitive: Vessel Sealer Curved Receives FDA
Clearance More
- Personalis: Expands Tempus Strategic
Collaboration to Bring Ultra-Sensitive Cancer
Recurrence Testing to Colorectal Cancer
Patients More
- Ultragenyx and Mereo BioPharma: UX143
Phase 3 Orbit Study for Osteogenesis
Imperfecta Progressing to Final Analysis More
More
More*
- Xaira Therapeutics: Appointment of Jeff
Jonker as President and Chief Operating
Officer More
|
|
 |
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Aqtual: Raises Over $30M as It Scales
Novel cfDNA Platform More
More*
More*
- Arcus Biosciences: New Employment Inducement
Grants More
- Benitec Biopharma: Operational Updates More
- 89bio: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- More on Peninsula Biotech Jasper
Therapeutics Laying Off Half Its Staff as Cash
Runs Low More*
- More on Revolution Lining Up Iambic’s AI
Platform in Discovery Collab Worth up to $25M
More
- Nurix Therapeutics: Second Quarter 2025
Financial Results and Provides a Corporate
Update More
- Renasant Bio, an Underdog in the Race To
Develop Kidney Disease Therapies, Raises
$54.5 Million More*
More*
More* More
- Soleno Therapeutics: Preliminary
Financial and Operational Results for the
Second Quarter Ended June 30, 2025 More
- Soleno Therapeutics: Pricing of $200 Million
Public Offering of Common Stock More
- Who Pays the Most in Biopharma? We Analyzed
Median Pay at 177 Companies More*
|
|
 |
| San
Francisco's most flexible contract
vivarium lab space: Start with a
few cages and grow. |
|
Learn More
→ |
|
|
- More on Gilead Partnering With the Global
Fund to Support Yeztugo Access Strategy on
Heels of FDA Nod More
- Stanford: People With 'Young Brains' Outlive
'Old-brained' Peers, Stanford Medicine
Scientists Find More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- Biotech Career Paths You Never Knew
Existed-10 Surprising Roles More*
- Career Blocks for Female Scientists Put
Under Scrutiny More
- Feature: What Defines Great Leadership? More
- ICYMI: The Future of Hiring: How Fractional
Talent is Reshaping The Workforce More
- ICYMI: Beyond Cautious Optimism: Why a
Hybrid Talent Model is the Future for Life
Sciences & Healthcare More
- ICYMI: Attracting Top Talent: How to Craft a
Compelling Job Description More
|
|
Event
Center
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Connecting the Clusters: A Global View of
Market Challenges & Opportunities in the
Race to Innovation July
10
- Bases & Breakthroughs: Life Sciences
Pregame + Phillies Game July
23
- BioScience Forum: Using Logic Gated CARs to
Drive Cancer Treatment July
23
- BVS and BioMed Realty in Partnership with
MassBio Biotech Community Event, Cambridge July
23
- Introducing LSWC & 2025 Report: National
Coordination for a Stronger Life Sciences
Workforce July
25
- WIB-Greater Boston: New & Interested
Member Virtual Information Session Aug
11
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
